Investment ThemesDetailed Quotes
Cancer Research
Watchlist
Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
- 1132.109
- -16.835-1.47%
Close Nov 12 16:00 ET
1147.610High1131.430Low
1147.419Open1148.944Pre Close97.34MVolume--Rise29.03P/E (Static)5.00BTurnover--Flatline0.70%Turnover Ratio884.95BMarket Cap9Fall874.17BFloat Cap
Constituent Stocks: 9Top Rising: PFE-0.19%
do
u
diva gal dive
Pfizer (PFE) is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, according to three people familiar with the matter.
The unit, now called Pfizer Hospital, was formed after Pfizer bought Hospira for about $17 billion in 2015. The pharma giant has hired Goldman Sachs to gauge initial interest from potential buyers, which include private equity firms and other phar...
Looking back at my recent investment decisions, I realized there were some interesting psychological factors at play. I had predicted that Tesla would likely surge following Trump’s successful election, yet I chose to invest in Pfizer instead—a stock that seemed “on the ground” with little attention from the market. In my mind, where the hype fades, potential often emerges. I believed th...
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +10 bps, the $Dow Jones Industrial Average (.DJI.US)$ climbed 69 bps, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.06%.
MACRO
In macroecon...
Think these before you buy at this moment before Trump and Kennedy are in office: Have they announced a plan to nail down supplier? Current rumor is they will fire a lot of dishonest CDC, NIH, FDA officers and cut funding a lot. If they find out things like RFK jr suspecte...
No comment yet